The effect of continuous normalization of serum hemolytic complement on the course of lupus nephritis: a five year prospective study.
We have completed a five year prospective study of the effect of continuous normalization of serum hemolytic complement (CH50) in 25 patients with lupus nephritis. At the end of five years 22 patients were being actively followed; 13 in a CH50 controlled group and nine in a CH50 uncontrolled group. Serial renal biopsy specimens were obtained from 19 patients. The results demonstrate a trend toward stabilization of renal histology, creatinine clearance and serum creatinine at a lower final mean dose of prednisone in the complement controlled group.
D000906:Antibodies / Q000032:analysis; D003165:Complement System Proteins / Q000032:analysis*; D003404:Creatinine / Q000378:metabolism; D004247:DNA / Q000276:immunology; D006801:Humans; D007668:Kidney / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D008657:Metabolic Clearance Rate; D009393:Nephritis / Q000097:blood* / Q000188:drug therapy / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D011446:Prospective Studies
D000906:Antibodies; D003165:Complement System Proteins; D004247:DNA; D003404:Creatinine; D011241:Prednisone